Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,512 | $2,386 | $3,947 | $4,987 |
| Dep. & Amort. | $3,002 | $3,119 | $2,336 | $1,834 |
| Deferred Tax | $0 | $0 | -$188 | -$4,039 |
| Stock-Based Comp. | $21 | $36 | $54 | $64 |
| Change in WC | -$1,351 | -$937 | -$1,388 | $260 |
| Other Non-Cash | -$707 | -$241 | -$544 | $841 |
| Operating Cash Flow | $4,477 | $3,414 | $4,218 | $3,949 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,410 | -$5,337 | -$5,889 | -$4,973 |
| Net Acquisitions | -$84 | -$924 | -$488 | $381 |
| Inv. Purchases | -$846 | -$943 | -$1,501 | -$1,425 |
| Inv. Sales/Matur. | $1,498 | $2,728 | $4,650 | $2,168 |
| Other Inv. Act. | $229 | -$302 | -$836 | -$9 |
| Investing Cash Flow | -$3,613 | -$4,778 | -$4,064 | -$3,857 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $410 | $1,724 | $3,747 | $1,811 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$238 | $0 | $0 | $0 |
| Dividends Paid | -$2,059 | -$2,455 | -$1,435 | -$1,103 |
| Other Fin. Act. | $885 | -$596 | $4,604 | -$716 |
| Financing Cash Flow | -$1,003 | -$1,327 | $4,428 | -$831 |
| Forex Effect | $28 | $74 | $128 | -$135 |
| Net Chg. in Cash | -$111 | -$1,668 | $4,710 | -$874 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,502 | $11,170 | $6,460 | $7,325 |
| End Cash | $9,391 | $9,502 | $11,170 | $6,451 |
| Free Cash Flow | $67 | -$1,922 | -$1,671 | -$1,024 |